Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amn Healthcare Services (AMN) Current Assets (2016 - 2025)

Amn Healthcare Services' Current Assets history spans 16 years, with the latest figure at $545.4 million for Q4 2025.

  • For Q4 2025, Current Assets fell 8.33% year-over-year to $545.4 million; the TTM value through Dec 2025 reached $545.4 million, down 8.33%, while the annual FY2025 figure was $545.4 million, 8.33% down from the prior year.
  • Current Assets reached $545.4 million in Q4 2025 per AMN's latest filing, down from $570.3 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $1.5 billion in Q1 2022 to a low of $545.4 million in Q4 2025.
  • Average Current Assets over 5 years is $870.3 million, with a median of $818.8 million recorded in 2021.
  • Peak YoY movement for Current Assets: skyrocketed 152.76% in 2021, then tumbled 32.18% in 2023.
  • A 5-year view of Current Assets shows it stood at $1.3 billion in 2021, then dropped by 18.93% to $1.1 billion in 2022, then fell by 23.04% to $841.7 million in 2023, then dropped by 29.32% to $594.9 million in 2024, then decreased by 8.33% to $545.4 million in 2025.
  • Per Business Quant, the three most recent readings for AMN's Current Assets are $545.4 million (Q4 2025), $570.3 million (Q3 2025), and $571.4 million (Q2 2025).